Epsilon Healthcare Limited (FRA:9TH0)

Germany · Delayed Price · Currency is EUR

0.0055

+0.0005 (10.00%)

Last updated: Oct 23, 2026, 8:04 AM CEST

Market Cap	4.89M +10.5%
Revenue (ttm)	8.22M +121.4%
Net Income	38.99K
EPS	0.00
Shares Out	n/a
PE Ratio	65.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,000
Open	0.0055
Previous Close	0.0050
Day's Range	0.0055 - 0.0055
52-Week Range	0.0045 - 0.0145
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known a... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2016

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 9TH0

Financial Performance

In 2025, Epsilon Healthcare's revenue was 9.39 million, an increase of 67.74% compared to the previous year's 5.60 million. Losses were -1.28 million, -76.73% less than in 2024.

Financial numbers in AUD Financial Statements